Tirzepatide in the UK: What It Is and What It Does (October 2026)

01 · The core answer

What is tirzepatide, and what does Mounjaro do?

Tirzepatide is the active medicine; Mounjaro is the brand name. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹

So when people ask "what is Mounjaro" or "what does Mounjaro do", the short answer is that it is a prescribed injection that changes appetite and digestion signals. Most people feel fuller sooner and less hungry between meals, which makes a reduced-calorie diet easier to follow.¹ It does not replace healthy eating or activity. It is a tool that works alongside them.

You may also see it written as Zepatide, Maunjaro, Mountjaro, Monjauro, Monjouro, Mounjara or Monjuro. They all point to the same product. Our guide to how to spell Mounjaro goes deeper.

02 · Your decision

Is tirzepatide relevant to you?

It is relevant if you are an adult looking at medically supported weight management, or if you have been prescribed it for type 2 diabetes. The licence covers adults only, and the decision belongs with a prescriber who can look at your health history, your current medicines and your goals.

Treatment is only supplied after a consultation reviewed by a GPhC-registered prescriber.¹ That matters because tirzepatide is not suitable for everybody, and a prescriber will check things a leaflet cannot, such as other medicines you take and conditions you have. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.

It may be a poor fit if you are hoping for a quick fix, if you are unwilling to change eating habits, or if you are looking for a cosmetic shortcut without medical oversight. It is a long-term medical treatment, and the evidence is built around people who combined it with lifestyle changes.²

03 · Next step

How to get tirzepatide in the UK

In the UK you can access tirzepatide through the NHS, where access is phased, or through a regulated online pharmacy such as ours. We are GPhC-registered (9012878), and the online consultation is free with no obligation. Payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

If you are ready to look at costs, the Mounjaro pen, with prices and consultation, shows every dose. The 2.5mg starting pen has a standard price of £169.99 per month, and new customers save £40 on their first order with code FIRST40. If you want the wider picture first, our weight loss clinic page explains how treatment and follow-up fit together.

Related guide: 30ml tirzepatide.

04 · How it works

How tirzepatide works in the body

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ Because stomach emptying slows, the way you feel after eating can change too. Many people find they naturally want smaller portions.

This dual action is what distinguishes Mounjaro from single-action medicines such as semaglutide (Wegovy and Ozempic).¹ Semaglutide acts on only one of those receptors. Whether the extra action matters for a given person is something a prescriber can discuss with you, and it is not a promise of a better individual result.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹

05 · What the evidence shows

What the trial evidence shows

The best-known weight-loss trial of tirzepatide is SURMOUNT-1, and its results must be read as averages. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Trial averages do not predict your own result. Some people lose more than the average, some lose less, and a prescriber can help you set realistic expectations.

The trial also reports how many people reached larger milestones. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

To make the percentages tangible: for someone starting at 100 kg, 20.9% is about 21 kg.

06 · Spellings and names

Mounjaro, Manjaro and other spellings

All of these spellings mean Mounjaro, the brand name for tirzepatide. The correct spelling is M-O-U-N-J-A-R-O.

Why does this matter beyond spelling? Because a misspelt product name on a website can be a warning sign. Genuine UK supply of Mounjaro comes from a registered pharmacy that can show its regulator number. Ours is GPhC 9012878, and you can check any pharmacy on the public register of the pharmacy regulator.¹²

If you landed here looking for the medicine, our short note on the Manjaro spelling and tirzepatide explains the mix-up, and the generic name is the same wherever you see it.

The brand name covers a single product in several strengths. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Treatment typically starts on the lowest strength and steps up under prescriber guidance, as set out in the product information.

If a seller offers something labelled with any of the misspelt names, treats it as a different product, or offers to supply without a consultation or prescription, walk away. A prescription-only medicine should always involve a prescriber review.

07 · NHS or private

NHS access versus private treatment

Mounjaro is available on the NHS, but access is being phased in over several years.⁴ That is the honest starting point for anyone asking whether they can get tirzepatide for free.

NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you think you might qualify on the NHS, speak to your GP first.

If you decide on private treatment, choose a pharmacy that is on the regulator's register, uses a real prescriber review and supplies genuine pens. Ours are supplied through official LillyDirect supply, direct from Eli Lilly's UK distribution. Delivery is free next-day tracked in temperature-controlled packaging, and same-day dispatch applies when you order by 3pm.

Private treatment is a personal choice, not a better or worse route. The medicine is the same licensed product, and what differs is who reviews you, how fast you can start and how you pay.

08 · Safety and side effects

Is tirzepatide safe, and what is the downside?

Tirzepatide is a licensed prescription medicine, and its safety depends on being prescribed to the right person and used as directed. It is supplied only after an online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity.¹

People often ask "what is the bad side of tirzepatide?" or "is tirzepatide hard on your body?" Like any medicine, it can cause side effects. Most are digestive: the most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.¹³ Read the leaflet before you start, and keep it to hand.

Because the medicine changes digestion and appetite, it is sensible to expect that your body will need to adjust, particularly when a dose changes. If nausea or vomiting is persistent or you cannot keep fluids down, contact your clinical team, because dehydration needs medical help straight away.

You can also report a suspected side effect through the MHRA Yellow Card scheme.¹⁹ Reporting helps regulators spot patterns across the whole population.

If you are on other medicines, tell the prescriber, because some combinations need review. Counterfeit or unregulated products are a separate and serious risk, and the MHRA publishes alerts about them.⁷

Ongoing monthly reviews are part of our aftercare, so a prescribing team keeps checking suitability. Repeat orders re-check suitability and there is no auto-shipping.

09 · Using the pen

Injecting and day-to-day use

Tirzepatide is injected once a week, under the skin, with a pre-filled KwikPen. The patient information leaflet gives step-by-step instructions, and every order from us includes needles, a sharps bin and injection guidance.¹³

Licensed injection sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection, and you should rotate the site with each dose. Follow the pen's instructions rather than relying on a forum tip, and ask your prescriber or pharmacist if you are unsure. Use the same day each week so the schedule becomes routine.

What not to do on tirzepatide is mostly common sense. Do not buy it without a prescription. Do not change the dose yourself or share a pen. Do not treat it as a reason to stop eating well, because it is meant to be used with a reduced-calorie diet and increased physical activity.¹ And do not ignore new symptoms. Report them to your prescriber.

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day. Never take two doses within 3 days of each other. Dose changes are made by the prescribing team, with at least 4 weeks on each dose, depending on how you respond.

10 · Other options

Tirzepatide compared with other medicines

Tirzepatide is one of several treatments used for weight management, and it differs from single-action medicines because it activates two receptors rather than one.¹ Semaglutide, sold as Wegovy for weight management, is the closest comparator; Ozempic is semaglutide licensed for type 2 diabetes and is not a UK weight-loss medicine.

Wegovy comes in a stepped dose ladder: 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, with the 2.4mg dose being the licensed maintenance dose for weight management.¹⁸ Liraglutide, supplied at 6mg per millilitre, is a daily injection, unlike once-weekly Mounjaro and Wegovy.

Which suits you depends on your health profile. Each is a licensed treatment, and a prescriber considers your health, your preferences and side-effect tolerance. Please do not compare numbers from separate trials as if they were a head-to-head test. They were run in different groups for different lengths of time.

Wegovy now also exists in tablet form, and further oral medicines are emerging.

Supplements marketed as natural alternatives are a different category entirely. They are low-cost and need no assessment, but they have no clinical oversight and nothing like the trial evidence behind licensed medicines. Dramatic weight-loss claims on such products should be treated with caution.

11 · Generic and patents

Unbranded, patented and combination products

In the UK, the licensed product is Mounjaro, made by Eli Lilly, and we supply the genuine KwikPen. Our pieces on unbranded versions and the patent question explain how this works.

You may also see products described as combining tirzepatide with a vitamin, such as pyridoxine. Those are not the licensed Mounjaro pen. Our page on pyridoxine combinations explains why we advise caution and how to tell what you are being offered.

The simple rule is this. If a product is not a genuine, prescribed, labelled pen from a registered pharmacy, you cannot be sure what is in it. The regulator's register and the MHRA's alerts are the places to check.⁷

If you are weighing cost, remember that the price shown is the price paid, with no hidden fees, and that our consultation is free. Klarna and pay-monthly options are available, with no subscription lock-in. Our prices are checked and dated, so you can see what applied on 10 October 2026.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹